Conventional Chondrosarcoma
3 clinical trials · Condition
◉ Watch Conventional Chondrosarcoma
| Record | Firm | Date |
|---|---|---|
| Study of INBRX-109 in Conventional Chondrosarcoma (NCT04950075) | Inhibrx Biosciences, Inc | 2021-09-23 |
| Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma (NCT02821507) | Leiden University Medical Center | 2014-06-01 |
| A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma (NCT01310816) | Infinity Pharmaceuticals, Inc. | 2011-02-01 |
Track Conventional Chondrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.